Literature DB >> 30946142

Understanding disclosed and cryptic HIV transmission risk via genetic analysis: what are we missing and when does it matter?

Manon Ragonnet-Cronin1, Emma B Hodcroft2, Joel O Wertheim3.   

Abstract

PURPOSE OF REVIEW: To discuss the recent HIV phylogenetic analyses examining HIV transmission patterns among and within risk groups. RECENT
FINDINGS: Phylodynamic analysis has recently been applied to multiple HIV outbreaks among people who inject drugs to determine whether HIV transmission is ongoing. Large-scale analyses of datasets of HIV sequences collected for drug-resistance testing provide population-level insights into transmission patterns. One focus across world regions has been to investigate whether age-disparity is a driver of HIV transmission. In sub-Saharan Africa, researchers have examined transmission between heterosexuals and MSM and between high prevalence fishing communities and inland communities. In the US and the UK, cryptic risk groups such as nondisclosed MSM and the partners of transgender women are increasingly being uncovered based on their position in densely sampled molecular transmission networks.
SUMMARY: Analysis of HIV genetic sequence can resolve viral transmission patterns between risk groups at unprecedented scales and levels of detail. Future research should focus on understanding the effect of missing data on inferences and the biases of different methods. Uncovering groups and patterns obscured from traditional epidemiolocal analyses is exciting but should not compromise the privacy of the groups in question.

Entities:  

Mesh:

Year:  2019        PMID: 30946142     DOI: 10.1097/COH.0000000000000537

Source DB:  PubMed          Journal:  Curr Opin HIV AIDS        ISSN: 1746-630X            Impact factor:   4.283


  6 in total

1.  Sorting by Race/Ethnicity Across HIV Genetic Transmission Networks in Three Major Metropolitan Areas in the United States.

Authors:  Manon Ragonnet-Cronin; Nanette Benbow; Christina Hayford; Kathleen Poortinga; Fangchao Ma; Lisa A Forgione; Zhijuan Sheng; Yunyin W Hu; Lucia V Torian; Joel O Wertheim
Journal:  AIDS Res Hum Retroviruses       Date:  2021-02-08       Impact factor: 1.723

2.  Pretreatment HIV drug resistance spread within transmission clusters in Mexico City.

Authors:  Margarita Matías-Florentino; Antoine Chaillon; Santiago Ávila-Ríos; Sanjay R Mehta; Héctor E Paz-Juárez; Manuel A Becerril-Rodríguez; Silvia J Del Arenal-Sánchez; Alicia Piñeirúa-Menéndez; Verónica Ruiz; Patricia Iracheta-Hernández; Israel Macías-González; Jehovani Tena-Sánchez; Florentino Badial-Hernández; Andrea González-Rodríguez; Gustavo Reyes-Terán
Journal:  J Antimicrob Chemother       Date:  2020-03-01       Impact factor: 5.790

3.  Methodological synthesis of Bayesian phylodynamics, HIV-TRACE, and GEE: HIV-1 transmission epidemiology in a racially/ethnically diverse Southern U.S. context.

Authors:  Kayo Fujimoto; Justin Bahl; Joel O Wertheim; Natascha Del Vecchio; Joseph T Hicks; Lambodhar Damodaran; Camden J Hallmark; Richa Lavingia; Ricardo Mora; Michelle Carr; Biru Yang; John A Schneider; Lu-Yu Hwang; Marlene McNeese
Journal:  Sci Rep       Date:  2021-02-08       Impact factor: 4.379

4.  Using Molecular Transmission Networks to Reveal the Epidemic of Pretreatment HIV-1 Drug Resistance in Guangxi, China.

Authors:  Fei Zhang; Bingyu Liang; Xu Liang; Zhaosen Lin; Yuan Yang; Na Liang; Yao Yang; Huayue Liang; Jiaxiao Jiang; Jiegang Huang; Rongye Huang; Shanmei Zhong; Cai Qin; Junjun Jiang; Li Ye; Hao Liang
Journal:  Front Genet       Date:  2021-09-10       Impact factor: 4.599

5.  Molecular Epidemiology of the HIV-1 Subtype B Sub-Epidemic in Bulgaria.

Authors:  Ivailo Alexiev; Ellsworth M Campbell; Sergey Knyazev; Yi Pan; Lyubomira Grigorova; Reneta Dimitrova; Aleksandra Partsuneva; Anna Gancheva; Asya Kostadinova; Carole Seguin-Devaux; William M Switzer
Journal:  Viruses       Date:  2020-04-14       Impact factor: 5.048

6.  A View of Human Immunodeficiency Virus Infections in the North-West Region of Romania.

Authors:  Cristian Jianu; Sorana D Bolboacă; Adriana Violeta Topan; Irina Filipescu; Mihaela Elena Jianu; Corina Itu-Mureşan
Journal:  Medicina (Kaunas)       Date:  2019-11-29       Impact factor: 2.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.